Assignee
TONIX PHARMA HOLDINGS LTD
IE·16 granted patents·11 pending applications·126 citations·filing 2014–2023
Top patents by PatentIndex Score
27 records- 0196US11839594B2Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochlorideTONIX PHARMA HOLDINGS LTD·Filed 2020·Granted Dec 12, 2023·3 cites·7 claims
- 0296US10117936B2Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochlorideTONIX PHARMA HOLDINGS LTD·Filed 2014·Granted Nov 6, 2018·28 cites·34 claims
- 0394US10864175B2Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochlorideTONIX PHARMA HOLDINGS LTD·Filed 2018·Granted Dec 15, 2020·4 cites·4 claims
- 0494US10736859B2Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochlorideTONIX PHARMA HOLDINGS LTD·Filed 2019·Granted Aug 11, 2020·5 cites·9 claims
- 0594US10322094B2Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochlorideTONIX PHARMA HOLDINGS LTD·Filed 2018·Granted Jun 18, 2019·12 cites·4 claims
- 0694US9636408B2Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochlorideTONIX PHARMA HOLDINGS LTD·Filed 2014·Granted May 2, 2017·19 cites·6 claims
- 0793US11737991B2Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochlorideTONIX PHARMA HOLDINGS LTD·Filed 2020·Granted Aug 29, 2023·2 cites·12 claims
- 0893US10357465B2Eutectic formulations of cyclobenzaprine hydrochlorideTONIX PHARMA HOLDINGS LTD·Filed 2015·Granted Jul 23, 2019·14 cites·14 claims
- 0993US9956188B2Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochlorideTONIX PHARMA HOLDINGS LTD·Filed 2017·Granted May 1, 2018·9 cites·9 claims
- 1089US11026898B2Eutectic formulations of cyclobenzaprine hydrochlorideTONIX PHARMA HOLDINGS LTD·Filed 2019·Granted Jun 8, 2021·6 cites·23 claims
- 1189US9474728B2Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprineTONIX PHARMA HOLDINGS LTD·Filed 2014·Granted Oct 25, 2016·15 cites·2 claims
- 1288US2024315988A1Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochlorideTONIX PHARMA HOLDINGS LTD·Filed 2023·Application pending·0 cites
- 1387US10864176B2Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochlorideTONIX PHARMA HOLDINGS LTD·Filed 2018·Granted Dec 15, 2020·3 cites·11 claims
- 1481US10722478B2Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprineTONIX PHARMA HOLDINGS LTD·Filed 2019·Granted Jul 28, 2020·2 cites·5 claims
- 1576US10449203B2Tianeptine oxalate salts and polymorphsTONIX PHARMA HOLDINGS LTD·Filed 2017·Granted Oct 22, 2019·3 cites·6 claims
- 1672US11826321B2Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditionsTONIX PHARMA HOLDINGS LTD·Filed 2018·Granted Nov 28, 2023·1 cites·7 claims
- 1772US2021128495A1Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprineTONIX PHARMA HOLDINGS LTD·Filed 2020·Application pending·0 cites
- 1862US2021177862A1Method for treating neurocognitive dysfunctionTONIX PHARMA HOLDINGS LTD·Filed 2020·Application pending·0 cites
- 1954US2017065538A1Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprineTONIX PHARMA HOLDINGS LTD·Filed 2016·Application pending·0 cites
- 2053US10946027B2Tianeptine oxalate salts and polymorphsTONIX PHARMA HOLDINGS LTD·Filed 2019·Granted Mar 16, 2021·0 cites·21 claims
- 2153US2021236619A1Stem cells comprising synthetic chimeric vaccinia virus and methods of using themTONIX PHARMA HOLDINGS LTD·Filed 2019·Application pending·0 cites
- 2253US2022380478A1Anti-cd154 antibodies and uses thereofTONIX PHARMA HOLDINGS LTD·Filed 2020·Application pending·0 cites
- 2348US2018193288A1Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprineTONIX PHARMA HOLDINGS LTD·Filed 2018·Application pending·0 cites
- 2446US2016256471A1Method for treating neurocognitive dysfunctionTONIX PHARMA HOLDINGS LTD·Filed 2016·Application pending·0 cites
- 2542US2022117915A1Methods of treating acute stress disorder and posttraumatic stress disorderTONIX PHARMA HOLDINGS LTD·Filed 2019·Application pending·0 cites
- 2640US2015258197A1Eutectic isometheptene mucateTONIX PHARMA HOLDINGS LTD·Filed 2015·Application pending·0 cites
- 2738US2022153780A1Salt forms of s-(n, n-diethylcarbamoyl)glutathioneTONIX PHARMA HOLDINGS LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TONIX PHARMA HOLDINGS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →